feed,title,long_url,short_url
Benzinga,Hoth Therapeutics Reports Being Set To Begin Phase 2 Study On First-Of-Its-Kind Skin Toxicity Ointment For Cancer Patients,https://benzinga.com/general/biotech/22/02/25330369/hoth-therapeutics-reports-being-set-to-begin-phase-2-study-on-first-of-its-kind-skin-toxicity-oin,https://bit.ly/3ALUrMJ
